Complete mesogastric excision for gastric cancer: is it the future of gastric cancer surgery?

complete mesogastric excision gastric cancer guidelines surgery surgical oncology

Journal

Personalized medicine
ISSN: 1744-828X
Titre abrégé: Per Med
Pays: England
ID NLM: 101238549

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 23 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: ppublish

Résumé

Gastric cancer remains undoubtedly one of the most common and deadly cancers worldwide. The global incidence shows wide geographic variation with a high prevalence in Asia. Besides that, there are evident differences in epidemiology, histopathology, tumor location, diagnosis and treatment strategy between east and west countries. Gastric cancer represents an aggressive disease, with many factors influencing its development and also recurrence after surgical resection. New knowledge of disease spread and new routes of metastases are now emerging and the 'novel' concept of complete mesogastric excision for gastric cancer is under consideration and debate. This article aims to analyze and highlight this new concept after a careful literature review, offering also a view toward the future.

Identifiants

pubmed: 37811582
doi: 10.2217/pme-2023-0028
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-466

Auteurs

Georgios D Lianos (GD)

Department of Surgery, University Hospital of Ioannina, Ioannina, 45500, Greece.

Christina D Bali (CD)

Department of Surgery, University Hospital of Ioannina, Ioannina, 45500, Greece.

Konstantinos Vlachos (K)

Department of Surgery, University Hospital of Ioannina, Ioannina, 45500, Greece.

Panagiota Drosou (P)

Department of Surgery, University Hospital of Ioannina, Ioannina, 45500, Greece.

Stefano Rausei (S)

Department of Surgery, Cittiglio-Angera Hospital, ASST Settelaghi, Cittiglio, 21033, Italy.

Michail Mitsis (M)

Department of Surgery, University Hospital of Ioannina, Ioannina, 45500, Greece.

Dimitrios Schizas (D)

First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, 11527, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH